MIMO Clinical Trial

Overview

About this study

Objectives

  • Primary objective: Determine if there is a clinically significant difference in percent Cobb curve correction in a low- vs. high-implant density cohort through a prospective randomized controlled trial.

Design and Outcomes

  • Randomized clinical trial of equivalence to test the efficacy and safety of low vs. high implant density instrumentation for spine deformity surgery in AIS patients with Lenke IA curve patterns.

Interventions and Duration

  • Intervention: low-implant density group or high-implant density group.
  • Duration: 2 years.

Sample Size and Population

  • Target population: 10 to 17 years old with AIS who will undergo instrumented spinal fusion.
  • Sample size needed (power = 90%) is 174 subjects with 87 in each group.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients aged ≥10 and ≤ 18 years
  • Male or Female
  • Diagnosis of idiopathic scoliosis for which surgery is recommended to prevent the curvature or to correct trunk disfigurement Lenke 1A curve pattern
  • Curve cobb of 45° to 65°
  • T5-T12 kyphosis measuring 0° to 40°
  • Spina bifida Oculta is permitted
  • Spondylolisthesis and Spondylolysis are permitted, as long as non- operative

Exclusion Criteria:

  • Prior spinal surgery
  • MRI abnormalities (including >4mm of Syrinx and/or Chiari malformation)
  • Neuromuscular or other serious co-morbidities
  • Thoracogenic or cardiogenic scoliosis
  • Associated syndrome or developmental delay
  • Unable or unwilling to firmly commit to returning for required follow-up

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

A. Noelle Larson, M.D.

Closed for enrollment

Contact information:

Vickie Treder CCRP

(507)538-3561

Treder.Vickie@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20149145

Mayo Clinic Footer